Ac immune announces interim phase 1b/2a data showing that its aci-35.030 anti-ptau alzheimer's vaccine generates a potent immune response

Observed strong induction of antibodies specific for pathological forms of tau with aci-35.030 treatment

ACIU Ratings Summary

ACIU Quant Ranking